Art

J-GLOBAL ID：200902216607819267   Reference number：07A0622910

Predominant Effect of A-Type Natriuretic Peptide on Reduction of Oxidative Stress During the Treatment of Patients With Heart Failure

心不全患者治療中の酸化ストレス軽減に与えるA型ナトリウム利尿ペプチドの優れた効果

Author (12)： SHONO Makoto (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.) ,  YOSHIMURA Michihiro (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.) ,  NAKAYAMA Masafumi (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.) ,  YAMAMURO Megumi (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.) ,  ABE Koji (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.) ,  SUZUKI Satoru (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.) ,  MIZUNO Yuji (Div. of Cardiology, Kumamoto Aging Res. Inst.) ,  SUGIYAMA Seigo (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.) ,  SAITO Yoshihiko (First Dep. of Internal Medicine, Nara Medical Univ.) ,  NAKAO Kazuwa (Dep. of Medicine and Clinical Sci., Kyoto Univ. Graduate School of Medicine) ,  YASUE Hirofumi (Div. of Cardiology, Kumamoto Aging Res. Inst.) ,  OGAWA Hisao (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.)
Material： Circulation Journal  (Circ J)
Volume： 71  Issue： 7  Page： 1040-1046 (J-STAGE)  Publication year： 2007 
JST Material Number： F0908A  ISSN： 1346-9843  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *cardiac insufficiency ,...
Semi thesaurus term： Reactive Oxygen Species

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0622910&from=J-GLOBAL&jstjournalNo=F0908A") }}

JST classification (2)： Clinical application of cardioactive drugs  (GW07030Y) ,  Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Substance index (2)： Carperitide ,  Furosemide

Reference (37)：

• 1. Saito Y, Nakao K, Nishimura K, Sugawara A, Okumura K, Obata K, et al. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: Beneficial effects on left ventricular function. Circulation 1987; 76: 115-124.
• 2. Yoshimura M, Yasue H, Morita E, Sakaino N, Jogasaki M, Kuroe M, et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991; 84: 1581-1588.
• 3. Suwa M, Seino Y, Nomachi Y, Matsuki S, Funahashi K. Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the `real world' of therapy. Circ J 2005; 69: 283-290.
• 4. Vollmar AM. The role of atrial natriuretic peptide in the immune system. Peptides 2005; 26: 1086-1094.
• 5. Mallat Z, Philip I, Lebret M, Chatel D, Maclouf J, Tedgui A. Elevated levels of 8-iso-prostaglandin F2α in pericardial fluid of patients with heart failure: A potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 1998; 97: 1536-1539.

Terms in the title (4)： 心不全 ,  患者治療 ,  酸化ストレス ,  ナトリウム利尿ペプチド